PlainRecalls
FDA Drug Low Class III Terminated

Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60

Reported: September 6, 2023 Initiated: August 23, 2023 #D-1139-2023

Product Description

Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60

Reason for Recall

Defective Container: slow leakage under the cap

Details

Units Affected
11,350 bottles
Distribution
Nationwide in the USA.
Location
Mississauga, N/A

Frequently Asked Questions

What product was recalled?
Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60. Recalled by Contract Pharmaceuticals Limited Canada. Units affected: 11,350 bottles.
Why was this product recalled?
Defective Container: slow leakage under the cap
Which agency issued this recall?
This recall was issued by the FDA Drug on September 6, 2023. Severity: Low. Recall number: D-1139-2023.